NASDAQ: REAXReal Brokerage Inc Stock
$4.67+0.05 (+1.08%)
Updated Apr 17, 2025
REAX Price
$4.67
Fair Value Price
$2.86
Market Cap
$945.67M
52 Week Low
$3.35
52 Week High
$6.75
P/E
-33.36x
P/B
29.42x
P/S
0.7x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.26B
Earnings
-$26.54M
Gross Margin
9.1%
Operating Margin
-1.96%
Profit Margin
-2.1%
Debt to Equity
1.69
Operating Cash Flow
$49M
Beta
0.79
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
REAX Overview
The Real Brokerage Inc. offers brokerage services for the real estate market through a network of agents. It also offers agents a mobile-focused tech platform to run their businesses. The company operates in 42 U.S. states and Canada. Real Brokerage was founded in 2014 and is headquartered in Toronto, Ontario, Canada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine REAX's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Real Estate Service
Industry Rating
B
REAX
Ranked#10 of 28
Ranked#10 of 28
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.29 | A | |
| $10.39 | A | |
| $14.62 | A |
Be the first to know about important REAX news, forecast changes, insider trades & much more!
REAX News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how REAX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
REAX ($4.67) is overvalued by 63.44% relative to our estimate of its Fair Value price of $2.86 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
REAX ($4.67) is not significantly undervalued (63.44%) relative to our estimate of its Fair Value price of $2.86 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
REAX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more REAX due diligence checks available for Premium users.
Valuation
REAX fair value
Fair Value of REAX stock based on Discounted Cash Flow (DCF)
Price
$4.67
Fair Value
$2.86
Overvalued by
63.44%
REAX ($4.67) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
REAX ($4.67) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
REAX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
REAX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-33.36x
Industry
85.07x
Market
27.98x
REAX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
29.42x
Industry
2.58x
REAX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
REAX's financial health
Profit margin
Revenue
$350.6M
Net Income
-$6.6M
Profit Margin
-1.9%
REAX's Earnings (EBIT) of -$24.82M... subscribe to Premium to read more.
Interest Coverage Financials
REAX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$86.6M
Liabilities
$54.5M
Debt to equity
1.69
REAX's short-term assets ($72.91M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
REAX's short-term assets ($72.91M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
REAX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$4.1M
Investing
$854.0k
Financing
-$6.8M
REAX's operating cash flow ($48.73M)... subscribe to Premium to read more.
Debt Coverage Financials
REAX vs Real Estate Service Stocks
Real Brokerage Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.